Cartesian Therapeutics, Inc.
RNAC
$10.50
-$0.07-0.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M |
| Total Depreciation and Amortization | 486.00K | 286.00K | 196.00K | 183.00K | 272.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.08M | 11.78M | 3.60M | 47.09M | 158.01M |
| Change in Net Operating Assets | 6.85M | 25.81M | -32.08M | -6.37M | -3.91M |
| Cash from Operations | -7.00M | 13.69M | -14.45M | -15.92M | -23.29M |
| Capital Expenditure | -705.00K | -6.20M | -1.59M | -602.00K | -64.00K |
| Sale of Property, Plant, and Equipment | 351.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 6.56M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -354.00K | -6.20M | -1.59M | -602.00K | 6.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 849.00K | 124.49M | 120.00K | 3.03M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 40.00M | 20.25M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -66.00K | -- | -- | -- | -6.17M |
| Cash from Financing | 783.00K | 124.49M | 120.00K | 43.03M | 14.08M |
| Foreign Exchange rate Adjustments | -15.00K | -15.00K | 14.00K | -5.00K | 16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.59M | 131.97M | -15.90M | 26.51M | -2.69M |